Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on Conditioning in Hong Kong
Total 0 results
Nothing found
Sponsors and Collaborators
ATTRaCT program by A*STAR BMRC Singapore
African Institute for Health and Development
CEVAC Core Lab, University Ghent
Menzis
Seed Health
Jennifer King
Sysmex Inostics GmbH
Chengdu Integrated TCM&Western Medicine Hospital
French National Society of Gastroenterology
Bioraba
R.Bos
Creighton University
Chul Kim
Zhengzhou First People's Hospital
Klinikum Freising
metaMe Health
Kyongtae Ty Bae, M.D., Ph.D.
Brandeis University
Meyer Children's Hospital, Florence, Italy
Intermed Hospital
View Full List
Medical Conditions
Burn Wound and Skin Graft Healing
Alert Fatigue, Health Personnel
Cell Phone Use
Bacterial Reduction Post-product Application
Parenteral Iron Therapy
Chronic Hepatitis C Virus Infection
B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma
Early Phase of Severe Sepsis and Septic Shock
Value-Based Health Insurance
Mild Traumatic Brain Injury; Concussion
Bleeding at Gastric Cancer
Systemic Lupus Erythematosus Nephritis
Hearing Loss, Bilateral or Unilateral
Failure; Cardiac
Chronic Myeloid Leukemia Blast Crisis (CML-BC, Ph+)
Plaque Type Psoriasis
Abdominal Aortic Aneurysm >= 5.5 Centimeters in Male (Disorder)
Adductor Pollicis
Root Canal Sealers
Regenerative Periodontal Treatment
View Full List
Drug Interventions
Insulin glargine
Soy protein isolate
Itraconazole
Estradiol plus MPA
PF-06650833
0.27 mg/kg, age≥65
Stem Cell Product
IDP-126 Vehicle Gel
Esketamine
30 mg CVL-231 Target Release, Fed
Nitric Oxide gas at 160ppm
LFG316 active drug
Follitropin beta liquid formulation
Galantamine CR
Leucovorin
Phase 2a, SQY51 (cohort 3)
Methylphenidate
Ciclesonide
Bupivacaine 0.5%
Fesoterodine
View Full List
CROs by country
Contract Research Organizations in Austria
Contract Research Organizations in Bangladesh
Contract Research Organizations in Belarus
Contract Research Organizations in Czech Republic
Contract Research Organizations in Ecuador
Contract Research Organizations in Greece
Contract Research Organizations in Kazakhstan
Contract Research Organizations in Luxembourg
Contract Research Organizations in Malta
Contract Research Organizations in Poland
Contract Research Organizations in Rwanda
Contract Research Organizations in Slovenia
Contract Research Organizations in Togo
CRO list by country
CROs in Burundi
SGS
All CROs in Burundi
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe